Cargando…

Current practice for diagnosing immediate drug hypersensitivity reactions in Korea

BACKGROUND/AIMS: Skin (STs) and drug provocation (DPTs) tests are essential for identifying the culprit drugs causing drug hypersensitivity reactions (DHRs). Several protocols have been developed for the identification of some culprit drugs, but they are neither thoroughly validated nor standardized...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Sung-Yoon, Yang, Min-Suk, Song, Woo-Jung, Cho, Sang-Heon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009158/
https://www.ncbi.nlm.nih.gov/pubmed/33401343
http://dx.doi.org/10.3904/kjim.2020.143
_version_ 1783672825798721536
author Kang, Sung-Yoon
Yang, Min-Suk
Song, Woo-Jung
Cho, Sang-Heon
author_facet Kang, Sung-Yoon
Yang, Min-Suk
Song, Woo-Jung
Cho, Sang-Heon
author_sort Kang, Sung-Yoon
collection PubMed
description BACKGROUND/AIMS: Skin (STs) and drug provocation (DPTs) tests are essential for identifying the culprit drugs causing drug hypersensitivity reactions (DHRs). Several protocols have been developed for the identification of some culprit drugs, but they are neither thoroughly validated nor standardized. Furthermore, language barriers may impede the exchange of information necessary for test standardization. METHODS: We searched the Korean literature for articles on drug hypersensitivity published from 1933 to 2016 using the KoreaMed search engine and archives of Korean journals. We reviewed and rated all articles according to the description of STs and DPTs. RESULTS: Of the 632 articles obtained in our initial search, 34 had adequate descriptions of 15 STs and 22 DPTs. Up to 27 healthy control subjects in STs were enrolled to determine non-irritating concentrations. The concentrations used for intradermal tests were commonly a 1/10 dilution of those used for skin prick tests. The interpretations of the STs were mostly similar among researchers. For DPTs, most procedures were single-arm open-label tests of various drugs. The initial dose ranged from a quarter dose to a single therapeutic dose, depending on the severity of the original hypersensitivity reaction. The interval between doses was usually 30 to 60 minutes, and a positive reaction usually occurred within twice the time of the original reaction. CONCLUSIONS: Efforts to distribute information are necessary to standardize protocols and better understand DHRs.
format Online
Article
Text
id pubmed-8009158
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-80091582021-04-02 Current practice for diagnosing immediate drug hypersensitivity reactions in Korea Kang, Sung-Yoon Yang, Min-Suk Song, Woo-Jung Cho, Sang-Heon Korean J Intern Med Original Article BACKGROUND/AIMS: Skin (STs) and drug provocation (DPTs) tests are essential for identifying the culprit drugs causing drug hypersensitivity reactions (DHRs). Several protocols have been developed for the identification of some culprit drugs, but they are neither thoroughly validated nor standardized. Furthermore, language barriers may impede the exchange of information necessary for test standardization. METHODS: We searched the Korean literature for articles on drug hypersensitivity published from 1933 to 2016 using the KoreaMed search engine and archives of Korean journals. We reviewed and rated all articles according to the description of STs and DPTs. RESULTS: Of the 632 articles obtained in our initial search, 34 had adequate descriptions of 15 STs and 22 DPTs. Up to 27 healthy control subjects in STs were enrolled to determine non-irritating concentrations. The concentrations used for intradermal tests were commonly a 1/10 dilution of those used for skin prick tests. The interpretations of the STs were mostly similar among researchers. For DPTs, most procedures were single-arm open-label tests of various drugs. The initial dose ranged from a quarter dose to a single therapeutic dose, depending on the severity of the original hypersensitivity reaction. The interval between doses was usually 30 to 60 minutes, and a positive reaction usually occurred within twice the time of the original reaction. CONCLUSIONS: Efforts to distribute information are necessary to standardize protocols and better understand DHRs. The Korean Association of Internal Medicine 2021-03 2021-01-05 /pmc/articles/PMC8009158/ /pubmed/33401343 http://dx.doi.org/10.3904/kjim.2020.143 Text en Copyright © 2021 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kang, Sung-Yoon
Yang, Min-Suk
Song, Woo-Jung
Cho, Sang-Heon
Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
title Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
title_full Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
title_fullStr Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
title_full_unstemmed Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
title_short Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
title_sort current practice for diagnosing immediate drug hypersensitivity reactions in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009158/
https://www.ncbi.nlm.nih.gov/pubmed/33401343
http://dx.doi.org/10.3904/kjim.2020.143
work_keys_str_mv AT kangsungyoon currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea
AT yangminsuk currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea
AT songwoojung currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea
AT chosangheon currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea